Taken together, these data demonstrate that the high expression of LncRNA GPNCA is responsible for the cancer incidence and poor overall survival, and drugs targeting GPNCA may represent a potential effective treatment for colon and liver cancer. This evidence concerns the gene GSK3B-DT and liver cancer.